A growing number of European nations are suspending use of the AstraZeneca COVID vaccine, one of three on the continent, after reports of blood clots and other problems among a small number of people. AstraZeneca says these are isolated cases. Dr. Kirsten Bibbins-Domingo, chair of epidemiology and biostatistics at the University of California, San Francisco, joins William Brangham to discuss.
Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts